REFERENCES

1. ADDONIZIO Jr., V. P.; STRAUSSS III, J. F.; MACARAK, E. J.; COLMAN, R. W.; EDMUNDS Jr., L. H. - Preservation of platelet number and function with prostaglandin E 1 during total cardiopulmoary bypass in rhesus monkeys. Surgery, 83: 619-625, 1978. [MedLine]

2. AGNELLI, G.; GRESELE, P.; CUNTO, M.; GALLAI, V.; NENCI, G. G. - Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis: case report. Br. J. Obstet. Gynaecol., 89: 681-682, 1982. [MedLine]

3. ASTEDT, B. & LIEDHOLM, P. - Tranexamic acid and fibrinolytic activity of the vessel wall. Experientia, 30: 776-777, 1974. [MedLine]

4. BEKÁSSY, Z. & ASTEDT, B. - Treatment with the fibrinolytic inhibitor tranexamic acid: risk for thrombosis? Acta Obstet. Gynecol. Scand., 69: 353-354, 1990. (Carta ao Editor). [MedLine]

5. BICK, R. L. - Alterations of hemostasis associated with cardiopulmonary bypass:' pathophysiology, prevention, diagnosis and management. Semin. Thromb. Hemost., 3: 59-82, 1976. [MedLine]

6. BIRNBAUM, D. E. & HOFFMEISTER, H. E. - Blood saving in open heart surgery. Stuttgart, Schattuer, 1990, 111p.

7. BLAUHUT, B.; GROSS, C.; NECEK, S.; DORAN, J. E.; SPATH, P.; LUNDSGAARD-HANSEN, P. - Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., 101: 958-967, 1991. [MedLine]

8. BLOMBACK, M.; NORÉN, I.; SENNING, A. - Coagulation disturbances during extracorporeal circulation and postoperative period. Acta Chir. Scand., 127: 433-445, 1964. [MedLine]

9. CAN drugs reduce surgical blood loss? Lancet, 1: 155-156, 1988. (Editorial). [MedLine]

10. COCHRAN, W. G. - Some methods for strenghtering the Comman X² test. Biometrics, 10: 417-451, 1954.

11. COSGROVE, D. M.; LOOP, F. D.; LYTLE, B. W.; GILL, C. C.; GOLDING, L. R.; TAYLOR, P. C.; FORSYTHE, S. B. - Determinants of blood utilization during myocardial revascularization. Ann. Thorac. Surg., 40: 380-384, 1985. [MedLine]

12. DERMAN, U. M.; RAND, P. W.; BARKER, N. - Fibrinolysis after cardiopulmonary bypass and its relationship to fibrinogen. J. Thorac. Cardiovasc. Surg., 51: 223-225, 1966.

13. DIETRICH, W.; BARANKAY, A.; DILTHEY, G.; HENZE, R.; NIEKAU, E.; SEBENING, F.; RICHTER, J. A. - Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application: clinical experience in 152 cardiac surgical patients. Thorac. Cardiovasc. Surg., 37: 92-98, 1989. [MedLine]

14. DIETRICH, W.; SPANNAGL, M.; KOCHUM, M.; WENDT, P.; SCHRAMM, W.; BARANKAY, A.; SEBENING, F.; RICHTER, J. A. - Influence of high-dose aprotin in treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology, 73: 1119-1126, 1990. [MedLine]

15. EDMUNDS Jr., L. H.; ELLISON, N.; COLMAN, R. W.; NIEWLAROWSKI, S.; RAO, A. K.; ADDONIZIO Jr., V. P.; STEPHENSON, L. W.; EDIE, R. N. - Platelet function during cardiac operation: comparison of membrane and bubble oxygenators. J. Thorac. Cardiovasc. Surg., 83: 805-812, 1982. [MedLine]

16. FISH, K. J.; SARQUIST, F. H.; VAN STEENNIS, C.; MITCHELL, R. S.; HILBERMAN, M.; JAMIESON, S. W.; LINET, O. I.; MILLER, D. C. - A prospective, randomized study of the effects os protacyclin on platelets and blood loss during coronary bypass operations. J. Thorac. Cardiovasc. Surg., 91: 436-442, 1986. [MedLine]

17. FRIEDENBERG, W. R.; MYERS, W.O.; PLOTKA, E. D.; BEATHARD, J. N.; KUMMER, D. J.; GATLIN, P. F.; STOIBER, D. L; RAY III, J. F.; SAUTTER, R. D. - Platelet dyisfunction associated with cardiopulmonary bypass. Ann. Thorac. Surg., 25: 298-305, 1978. [MedLine]

18. GANS, H.; SUBRAMANIAN, V.; JOHN, S.; CASTAÑEDA, A. R.; LILLEHEI, C. W. - Theoretical and practical (clinical) considerations concerning proteolytic enzymes and their inhibitors with particular reference to changes in the plasminogen-plasmin system observed during assisted circulation in man. Ann. N. Y. Acad. Sci., 146: 721-736, 1968. [MedLine]

19. GOMES, M. M. R. & McGOON, D. C. - Bleeding patterns after open-heart surgery. J. Thorac. Cardiovasc. Surg., 60: 87-97, 1970. [MedLine]

20. GOMES, O. M.; FREITAS NETO, A. G.; WOLOSKER, M.; LANGER, B.; DUBIEU, W. K.; ZERBINI, E. J. - Antifibrinolíticos e circulação extracorpórea. Rev. Hosp. Clin. Fac. Med. S. Paulo, 27: 209-213, 1972.

21. GRAM, J.; JANETZKO, T.; JESPERSEN, J.; BRUHN, H. D. - Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb. Haemost., 63: 241-145, 1990.

22. HAVEL, M.; TEUFELSBAUER, H.; KNOBL, P.; DALMATINER, R.; JAKSCH, P.; ZWOLFER, W.; MULLER, M.; VUKOVICH, T. - Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. J. Thorac. Cardiovasc. Surg., 101: 968-972, 1991. [MedLine]

23. HARDER, M. P.; EIJSMAN, L.; ROOZENDALL, K. J.; VAN OEVEREN, M.; WILDEVUUR, C. R. H. - Aprotinin reduces intraoperative an postoperative blood loss in membrane oxygenator cardiopulmonary bypass. Ann. Thorac. Surg., 51: 936-941, 1991. [MedLine]

24. HOLLANDER, M. & WOLFE, D. A. - Nonparametric statistical methods. New York, John Wiley & Sons, 1973. 503p.

25. HOPE, A. F.; HEYNS, A.; LOTTER, M. G.; VAN REENEN, O. R.; KOCK, F.; BADENHORST, P. N.; PIETERS, H.; KOTZE, H.; MEYER, J. M.; MINNAAR, P. C. - Kinetics and sites of sequestration of indium 111 - labeled human platelets during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., 81: 880-886, 1981. [MedLine]

26. HORROW, J. C.; HLAVACEK, J.; STRONG, M. D.; COLLIER, W.; BRODSKY, I.; GOLDMAN, S. M.; GOEL, I. P. - Prophylactic tranexamic acid decreases bleeding after cardiac operations. J. Thorac. Cardiovasc.Surg., 99: 70-74, 1990. [MedLine]

27. HORROW, J. C.; VAN RIPER, D. F.; STRONG, M. D.; BRODSKY, I.; PARMET, J. L. - Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation, 84: 2063-2070, 1991. [MedLine]

28. JONG, J. C. F.; NELEMS, J. M.; SIBINGA, C. T. S.; WILDEVUUR, C. R. H. - The influence of tranexamic acid on thrombocytopenia caused by artificial surfaces. Trans. Am. Soc. Artif. Intern. Organs, 208: 596-603, 1974.

29. KEVY, S. V.; BERHARD, W. F.; McMAHON, C. I, - Pathogenesis and prophylactic treatment of fibrinolysis in open-heart surgery. Surg. Forum., 16: 65-66, 1965. [MedLine]

30. KIRKLIN, J. W. & BARRAT-BOYES, B. G. - Hipothermia, circulatory arrest and cardiopulmonary bypass. In: Cardiac surgery. New York, John Wiley & Sons, 1986. p. 29-82.

31. KIRKLIN, J. W.; KIRKLIN, J. K.; LELL, W. A. - Cardiopulmonary bypass for cardiac surgery. In: SABISTON Jr., D. C. & SPENCER, F. C. - Gibbon's surgery of the chest. 4. ed. Philadelphia, W. B. Saunders Company, 1983. p. 909-925.

32. KUCUK, O.; KWAAN, H. C.; FREDERICKSON, J.; WADE, L.; GREEN, D. - Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation. Am. J. Hematol., 23: 223-229, 1986. [MedLine]

33. LAMBERT, C. J.; MORENGO-ROWE, A. J.; LEVESON, J. E.; GREEN, R. H.; THIELE, J. P.; GEISLER, G. F.; ADAM, M.; MITCHEL, B. F. - The treatment os postperfusion bleeding using epsilon-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate. Ann. Thorac. Surg., 28: 440-444, 1979. [MedLine]

34. LOURES, D. R. R.; VERGINELLI, G.; MARCIAL, M. B.; AMARAL, R. G.; ZERBINI, E. J. - Estudo da coagulação nos pacientes operados com circulação extracorpórea sob o uso per-operatório de ácido trans-4-amino-metil-ciclohexano carboxílico. Rev. Bras. Clin. Terap., 2: 161-166, 1973.

35. MAMMEN, E. F.; THAL, A. P.; KATZ, W. - Aplicação do Trasylol na circulação extracorpórea. Rev. Bras. Med., 25: 483-487, 1986.

36. NAEYE, R. L. - Thrombotic state after a hemorragic diathesis, a possible complication of therapy with epsilon-aminocaproic acid. Blood, 19: 694-701, 1962. [MedLine]

37. OEVEREN VAN, W.; JANSEN, N. J. G.; BIDSTRUP, B. P.; ROYSTON, D.; WESTABY, S.; NEUHOF, H.; WILDEVUUR, C. R. H. - Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann. Thorac. Surg., 44: 640-645, 1987. [MedLine]

38. OKAMOTO, S. & OKAMOTO, U. - Amino-methyl-ciclohexane-carboxylic acid (AMCHA): a new potent inhibitor of fibrinolysis. Keio J. Med., 11: 106-111, 1962.

39. OKAMOTO, S.; OSHIBA, S.; MIHARA, H.; OKAMOTO, U. - Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action. Ann. N. Y. Acad. Sci., 146: 414-429, 1968. [MedLine]

40. OKAMOTO, S.; SATO, S.; TAKADA, Y.; OKAMOTO, U. - An active stereo-isomer (trans-form) of AMCHA and its antifibrinolytic (antiplasminic) action in vitro and in vivo. Keio J. Med., 13: 177-185, 1964. [MedLine]

41. PORTER, J. M.; SILVER, D.; SABISTON Jr., D. C. - Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg., 56: 869-877, 1968.

42. RATNOFF, O. D. - Epsilon-aminocaproic acid: a dangerous weapon. N. Engl. J. Med., 280: 1124-1125, 1969. [MedLine]

43. RYDIN, E. & LUNDBERG, P. O. - Tranexamic acid and intracranial thrombosis, Lancet, 2 (7975): 49, 1976 (Carta ao Editor). [MedLine]

44. SALZMAN, E. W.; WEINSTEIN, M. J.; WEITRANUB, R. M.; WARE, J. A.; THURER, R. L.; ROBERTSON, L.; DONOVAN, A.; GAFFNEY, T.; BERTELE, V.; TROLL, J.; SMITH, M.; CHUTE, L. E. - Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: a double trial. N. Eng. J. Med., 314: 1402-1406, 1986.

45. SIEGEL, S. (ed.) - Estatística não paramétrica para as ciências do comportamento, São Paulo, McGraw-Hill do Brasil, 1975.

46. SOSLAU, G.; HORROW, J. C.; BRODSKY, I. - Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am. J. Hematol., 38: 113-119, 1991. [MedLine]

47. TAMARI, Y.; ALEDORT, L.; PUSZKIN, E.; DEGRAN, T. J.; WAGNER, N.; KAPLITT, M. J.; PEIRCE II, E. C. - Functional changes in platelets during extracorporeal circulation. Ann. Thorac. Surg., 19: 639-647, 1975. [MedLine]

48. TICE, D. A.; REED, G. E.; CLAUSS, R. H.; WORTH, M. H. - Hemorrhage due to fibrinolysis with open-heart operations. J. Thorac. cardiovasc. Surg., 46: 673-679, 1963. [MedLine]

49. TICE, D. A. & WORTH, M. H. - Recognition and treatment of postoperative bleeding associated with open-heart surgery. Ann. N. Y. Acad. Sci., 146: 745-753, 1968. [MedLine]

50. TICE, D. A.; WORTH, M. H.; CLAUSS, R. H.; REED, G. H. - The inhibition of trasylol of fibrinolytic activity associated with cardiovascular operations. Surg. Gynec. Obstet., 119: 71-74, 1964.

51. VANDER SALM, T. J.; ANSEL, J. E.; OKIKE, O. N.; MARSICANO, T. H.; LEW, R.; STEPHENSON, W. P.; ROONEY, K. - The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study. J. Thorac. Cardiovasc. Surg., 95: 538-540, 1988. [MedLine]

52. VESTRAETE, M. - Clinical application of inhibitors of fibrinolysis. Drugs, 29: 236-261, 1985. [MedLine]

53. WOO, K. S.; TRE, L. K. K.; WOO, J. L. F.; OWEN, J. V. - Massive pulmonary thromboembolism after antifibrinolytic therapy. Ann. Emerg. Med., 18: 116-117, 1989. [MedLine]